
Chief Investigator: Professor Michael Eddleston
Number and location of participating sites (by region/ country): UK 5 sites
ISRCTN number: 14373275
Funder: Medical Research Council (MRC) DPFS
Start and End date
Of grant award: 01 Feb 2024 – 31 Jul 2028
Of recruitment:
01 Oct 2024 - 31 May 2025 (Stage 1)
01 Dec 2025 - 30 Jun 2026 (Stage 2)
01 Jan 2027 – 31 Jan 2028 (Stage 3)
Current Status: Recruiting to Stage 1
Trial Website: N/A
UK GDPR Privacy Statement: Within patient information booklet
Sponsor: ACCORD https://www.accord.ed.ac.uk/
Chief Investigator: Professor Michael Eddleston, Centre for Cardiovascular Science, The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh BioQuarter, Edinburgh, EH16 4TJ
Trial Manager: Edinburgh Clinical Trials Unit, Usher Building, The University of Edinburgh, 5‒7 Little France Road, Edinburgh BioQuarter ‒ Gate 3 EDINBURGH EH16 4UX Email: rufus.trial@ed.ac.uk
ECTU involvement: Trial Management / Statistics / Database and randomisation service provision